Publication Details
Issue: Vol 1, No 10 (2024)
Pages: 175-191
ISSN: 2997-9331
Abstract
In the field of oncology, cross-sectional imaging has undergone a monumental shift in the paradigm of diagnosis and monitoring response to therapy in patients affected by solid tumors. Over the years, the evolution of FDG PET (Fluorodeoxyglucose Positron Emission Tomography) has revolutionized the way we evaluate and manage these patients.